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preconditioning. Am J Physiol Heart Circ Physiol 316: H743–H750,
2019. First published January 25, 2019; doi:10.1152/ajpheart.
00071.2018.—Adenosine is involved in classic preconditioning in
most species and acts especially through adenosine A1 and A3 recep-
tors. The aim of the present study was to evaluate whether remote
ischemic preconditioning (rIPC) activates adenosine A1 receptors and
improves mitochondrial function, thereby reducing myocardial infarct
size. Isolated rat hearts were subjected to 30 min of global ischemia
and 60 min of reperfusion [ischemia-reperfusion (I/R)]. In a second
group, before isolation of the heart, a rIPC protocol (3 cycles of
hindlimb I/R) was performed. Infarct size was measured with tetra-
zolium staining, and Akt/endothelial nitric oxide (NO) synthase
(eNOS) expression/phosphorylation and mitochondrial function were
evaluated after ischemia at 10 and 60 min of reperfusion. As expected,
rIPC significantly decreased infarct size. This beneficial effect was
abolished only when 8-cyclopentyl-1,3-dipropylxanthine (adenosine
A1 receptor blocker) and NG-nitro-L-arginine methyl ester (NO syn-
thesis inhibitor) were administered during the reperfusion phase. At
the early reperfusion phase, rIPC induced significant Akt and eNOS
phosphorylation, which was abolished by the perfusion with an
adenosine A1 receptor blocker. I/R led to impaired mitochondrial
function, which was attenuated by rIPC and mediated by adenosine A1
receptors. In conclusion, we demonstrated that rIPC limits myocardial
infarct by activation of adenosine A1 receptors at early reperfusion in
the isolated rat heart. Interestingly, rIPC appears to reduce myocardial
infarct size by the Akt/eNOS pathway and improves mitochondrial
function during myocardial reperfusion.
NEW & NOTEWORTHY Adenosine is involved in classic precon-
ditioning and acts especially through adenosine A1 and A3 receptors.
However, its role in the mechanism of remote ischemic precondition-
ing is controversial. In this study, we demonstrated that remote
ischemic preconditioning activates adenosine A1 receptors during
early reperfusion, inducing Akt/endothelial nitric oxide synthase
phosphorylation and improving mitochondrial function, thereby re-
ducing myocardial infarct size.
mitochondria; myocardial infarction; remote ischemic precondition-
ing
INTRODUCTION
Remote ischemic preconditioning (rIPC) is a cardioprotec-
tive phenomenon by which transient nonlethal ischemia and
reperfusion of one organ or tissue confers resistance to a later
episode of lethal ischemia-reperfusion (I/R) injury in a remote
organ or tissue (20, 41).
The rIPC phenomenon has been extensively studied in the
last 25 yr. However, some aspects of its mechanism remain
unknown (27). Some authors have shown that the cardiopro-
tective signal transference from the peripheral organ to the
target organ involved humoral factors (10), neural pathways
(12, 36), or a neurohumoral interaction (21). In a previous
study, we showed that hindlimb rIPC triggers cardiac signaling
before myocardial ischemia (13). However, we did not study
the cellular and molecular changes that occur during myocar-
dial reperfusion.
Adenosine is an endogenous nucleoside that modulates cel-
lular homeostasis (42), and different studies have shown that it
could likely trigger limb, renal, mesenteric, and carotid artery
rIPC (11, 15, 40, 43). In this sense, it is unknown whether rIPC
increases the local adenosine concentration in the remote
tissue/organ and stimulates the neurogenic pathway (31) and/or
whether adenosine participates directly at the cardiac level.
Different authors have shown adenosine participation before
myocardial ischemia (31, 40). However, the role of this nucle-
oside during myocardial reperfusion in hearts subjected to rIPC
has not been studied, nor has its potential modulatory effect
over mitochondrial function.
Therefore, the aim of this work was to evaluate the role of
the adenosine A1 receptor in the cardioprotective effects of
rIPC, focusing on the mechanisms involving Akt/endothelial
* R. J. Gelpi and M. Donato contributed equally to this work.
Address for reprint requests and other correspondence: R. J. Gelpi, Institute
of Cardiovascular Pathophysiology, Faculty of Medicine, Univ. of Buenos
Aires, 950 J. E. Uriburu, 2nd floor, Buenos Aires C1114AAD, Argentina
(e-mail: rgelpi@fmed.uba.ar).
Am J Physiol Heart Circ Physiol 316: H743–H750, 2019.
First published January 25, 2019; doi:10.1152/ajpheart.00071.2018.
0363-6135/19 Copyright © 2019 the American Physiological Societyhttp://www.ajpheart.org H743
Downloaded from journals.physiology.org/journal/ajpheart (152.170.035.163) on April 26, 2021.




Experiments were performed on male Sprague-Dawley rats (60–70
days old, 200250 g) supplied by the animal facility of the Faculty of
Pharmacy and Biochemistry, University of Buenos Aires. The proce-
dures used in this study were approved by the Animal Care and
Research Committee of the University of Buenos Aires (protocol no.
2948/10) and were in compliance with the National Institutes of
Health Guide for the Care and Use of Laboratory Animals (2011).
Surgical Procedures
In accordance with guidelines for experimental models of myocar-
dial ischemia and infarction (3, 5, 32), rats were anesthetized with
urethane (65 mg/kg ip) and intubated for mechanical ventilation. The
level of anesthesia was assessed by loss of pedal reflex (toe pinch).
Afterward, the left femoral or axillar artery was dissected and ex-
posed, and animals were randomized into different experimental
groups (see below).
After completion of the in vivo surgical procedure, animals were
euthanized, and hearts were rapidly excised and mounted on a Lan-
gendorff apparatus by the aortic root in 1 min. Each heart was
perfused with Krebs-Henseleit buffer containing 118.5 mM NaCl, 4.7
mM KCl, 24.8 mM NaHCO3, 1.2 mM KH2PO4, 1.2 mM MgSO4, 1.5
mM CaCl2, and 10 mM glucose and bubbled with a 95% O2-5% CO2
gas mixture at 37°C with final pH at 7.2–7.4. Two electrodes were
secured to the epicardial surface and connected to a pacemaker with
a constant heart rate of 275 beats/min.
A saline-filled latex balloon connected by a catheter to a pressure
transducer (Deltram II, Utah Medical System) was inserted into the
left ventricle (LV). The volume of the balloon was adjusted to achieve
a LV end-diastolic pressure of 8–10 mmHg. Coronary perfusion
pressure (CPP) was also recorded, and coronary flow was adjusted to
obtain a CPP of 70 mmHg during the initial stabilization period.
This flow was kept constant throughout the experiment.
Experimental Groups
I/R group. Rats were anesthetized, and the left femoral artery was
dissected and exposed as described above (Fig. 1). After 30 min of
monitoring, hearts were excised and perfused according to the Lan-
gendorff technique. After 15 min of stabilization, myocardial infarc-
tion was induced by 30 min of global no-flow ischemia followed by
60 min of reperfusion. Global no-flow ischemia was induced by
abruptly decreasing the total coronary flow provided by the perfusion
pump.
rIPC group. After rats had been anesthetized and the left femoral
artery dissected and exposed, animals were remotely preconditioned
by a three-cycle hindlimb ischemia (5 min) and reperfusion (5 min)
protocol by occlusion of the femoral artery with a vascular clamp.
Subsequently, hearts were subjected to the same protocol used in the
I/R group (30 min of global no-flow ischemia followed by 60 min of
reperfusion) to induce myocardial infarction.
rIPC  8-cyclopentyl-1,3-dipropylxanthine group. The same pro-
tocol as used in the rIPC group was performed, but 8-cyclopentyl-
1,3-dipropylxanthine (DPCPX; 100 g/kg iv), a selective adenosine
A1 receptor blocker, was administered 5 min before the rIPC protocol.
Myocardial infarction was induced using the above-mentioned proto-
col.
rIPC  DPCPX (reperfusion) group. The same protocol as used in
the rIPC group was performed, but at the onset of myocardial
reperfusion, DPCPX (1 M) was added to Krebs-Henseleit buffer.
The drug was perfused during the first 10 min of reperfusion [rIPC 
DPCPX (R) group].
rIPC  NG-nitro-L-arginine methyl ester (reperfusion) group. The
same protocol as used in the rIPC group was performed, but at the
onset of myocardial reperfusion, NG-nitro-L-arginine methyl ester
(L-NAME; 100 mmol/l) was administered. The drug was perfused
during the first 10 min of reperfusion [rIPC  L-NAME (R) group].
Two additional groups were performed in which the adenosine A1
receptor blocker (DPCPX) and the NO synthase inhibitor (L-NAME)
were administered in nonpreconditioned ischemic hearts during the
first 10 min of reperfusion.
Infarct Size Measurement
After 1 h of reperfusion, hearts were frozen and cut into 2-mm-
thick transverse slices from the apex to base. Sections were incubated
for 20 min in 1% triphenyltetrazolium chloride (pH 7.4, 37°C) and
then immersed in 10% formalin. With this technique applied, viable
sections are stained red, whereas infarct areas remain unstained.
Finally, all slices were then scanned on a flatbed digital scanner.
Infarct size was determined by semiautomatic computer planimetry
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Fig. 1. Representative scheme of the experimental
protocols. Dashed arrows indicate the time when
tissue samples were collected to measure protein
expression and mitochondrial function involved in
the remote ischemic preconditioning (rIPC) mecha-
nism. DPCPX, 8-cyclopentyl-1,3-dipropylxanthine;
I/R, ischemia (I)-reperfusion (R); L-NAME, NG-ni-
tro-L-arginine methyl ester.
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(Image Pro Plus, version 4.5, Media Cybernetics). Infarct size was
expressed as a percentage of the LV area.
Western Blot
Samples from LV of animals subjected to I/R, rIPC, and rIPC 
DPCPX (R) protocols were taken at 10 min of reperfusion. Samples
were homogenized in 3 volumes (wt/vol) of ice-cold homogenization
buffer [150 mM NaCl, 50 mM Trizma·HCl, 1% (vol/vol) sodium
deoxycholate, 1 mM EGTA, 1 mM NaF, 1 mM PMSF, and 1 mM
sodium pervanadate]. All reactants (Sigma-Aldrich, St. Louis, MO)
and a protease inhibitor cocktail (4%, Roche, Hertfordshire, UK) at
pH 8.0 were centrifuged at 10,507 g for 10 min at 4°C. These proteins
in the supernatant were quantified by the Lowry method. Equal
amounts of proteins (80 g) were subjected to 8% SDS-PAGE and
transferred to nitrocellulose membranes. After being blocked for 1 h
in 3% (wt/vol) BSA in PBS, membranes were incubated overnight at
4°C with the corresponding primary antibodies: rabbit anti-phospho-
Akt antibody (catalog no. 5012, RRID:AB_2224726, 1:1,000 dilution,
Cell Signaling Technology, Danvers, MA) (12) and rabbit anti-
phospho-eNOS (catalog no. 9570, 1:750 dilution, Cell Signaling
Technology) (12). Blots were hybridized with secondary antibody
coupled to horseradish peroxidase (dilution 1:5,000, Santa Cruz Bio-
technology, Dallas, TX). Complexes were visualized by chemilumi-
nescence detection (Pierce ECL Western blotting substrate). Mem-
branes were stripped and reprobed with anti-Akt (Ser473) (catalog no.
4691, 1:1,000 dilution, Cell Signaling Technology) (12) and anti-
eNOS antibody (Ser1177) (catalog no. 1133, 1:750 dilution, Cell
Signaling Technology) (12). Densitometric analysis of the bands was
performed using ImageJ (National Institutes of Health, Bethesda,
MD). Protein band densities were normalized to Akt and eNOS
content.
Mitochondrial Respiration
Samples from the LV (n  6 LVs/group) were taken at 10 and 60
min of reperfusion, and mitochondrial purified fractions were obtained
from tissue homogenates by differential centrifugation (34). Mito-
chondrial O2 consumption was followed polarographically with a
Clark-type O2 electrode (Hansatech Oxygraph, Hansatech Instru-
ments, Norfolk, UK) for high-resolution respirometry at 30°C.
Freshly isolated heart mitochondria (0.15 mg protein/ml) were incu-
bated in respiration buffer (120 mM KCl, 5 mM KH2PO4, 1 mM
EGTA, 3 mM HEPES, and 1 mg/ml fatty acid-free BSA, pH 7.4)
supplemented with 2 mM malate and 5 mM glutamate. An initial rest
state respiration (state 4) was established under these conditions,
which was then switched to active state respiration (state 3) by the
addition of 125 M ADP. The respiratory control ratio (RCR) was
calculated as state 3/state 4 respiration rates. Results are expressed as
nanograms of atmospheric O per minute per milligram of protein (34).
Mitochondrial ATP Production Rate
A chemiluminescent assay based on the luciferin-luciferase system
was used (16). Freshly isolated heart mitochondria (0.25 mg protein/
ml) were incubated in respiration buffer supplemented with 40 M
D-luciferin and 0.05 g/ml luciferase. ATP production was triggered
by the addition of 3 mM malate, 1.25 mM glutamate, and 1 mM ADP
to the reaction well. Chemiluminescence emission was followed as a
function of time in a Varioskan LUX multimode microplate reader
(ThermoFisher Scientific, Waltham, MA) at 30°C. Oligomycin (2
M) was used as a negative control to establish basal signal levels. A
calibration curve was performed using ATP as the standard, and the
ATP production rate was expressed as nanomoles of ATP per minute
per milligram of protein.
Mitochondrial H2O2 Production Rate
The mitochondrial H2O2 production rate was evaluated by the
Amplex red-horseradish peroxidase (HRP) method (8). The reaction
mixture consisted of 125 mM sucrose, 65 mM KCl, 10 mM HEPES,
2 mM KH2PO4, 2 mM MgCl2, and 0.01% (wt/vol) BSA (pH 7.2)
supplemented with 2 mM malate and 5 mM glutamate as mitochon-
drial respiratory substrates. After an initial stabilization period, freshly
isolated heart mitochondria (0.25 mg protein/ml) were added to the
reaction mixture together with 25 M Amplex red and 0.5 U/ml HRP.
Resorfurin formation resulting from Amplex red oxidation by HRP
bound to H2O2 was measured in a Varioskan LUX multimode micro-
plate reader (ThermoFisher Scientific) at 563 nm (excitation) and 587
nm (emission) at 30°C. Controls in the absence of isolated mitochon-
dria or HRP or in the presence of catalase indicated that nonspecific
probe oxidation was minimal (1%). A calibration curve was per-
formed using H2O2 solutions as standards, and the mitochondrial
H2O2 production rate was expressed as nanomoles per minute per
milligram of protein.
Mitochondrial Membrane Potential
Freshly isolated heart mitochondria (25 g protein/ml) were incu-
bated in respiration buffer with the potentiometric cationic probe
3,3=-dihexyloxacarbocyanine iodide (DiOC6; 30 nM) in the dark at
37°C for 20 min. After the incubation period, mitochondria were
acquired in a FACScalibur flow cytometer (BD Biosciences, Franklin
Lakes, NJ). Samples were gated based on light-scattering properties,
and 20,000 events/sample were collected. 10-N-nonyl acridine orange
(100 nM) was used to selectively stain mitochondria and to evaluate
their purity due to its ability to selectively bind to cardiolipin at the
inner mitochondrial membrane (20). To quantify the resulting changes
in membrane potential after the addition of 2 mM malate and 5 mM
glutamate to the reaction mixture, the DiOC6 signal was analyzed in
the FL-1 channel with FlowJo software (FlowJo, Ashland, OR), and
the arithmetic mean values of the median fluorescence intensities were
obtained. Total depolarization induced by 2 M m-CCCP was used as
a positive control. Mitochondrial preparations that showed no changes
in membrane potential under this condition were discarded (35).
Statistical Analysis
Data are expressed as means  SE. Intergroup comparisons were
carried out using one-way ANOVA followed by t-tests, with the
P value adjusted for multiple comparisons using the Bonferroni test.
Data comparisons were not significant unless the corresponding
P value was 0.05/k, where k represents the number of comparisons.
Intragroup comparisons were analyzed by two-factor repeated-mea-
sures ANOVA.
RESULTS
Figure 2 shows the infarct size induced by 30 min of global
ischemia followed by 120 min of reperfusion expressed as a
percentage of the LV area. In the I/R group, infarct size was
46.9  0.8%, whereas rIPC decreased infarct size to
34.7  1.3% (P  0.05 vs. the I/R group), thus displaying
significant cardioprotection by rIPC. The administration of
DPCPX (adenosine A1 receptor blocker) before the rIPC pro-
tocol did not influence the infarct-limiting effects of rIPC.
However, blockade of the adenosine receptor during 10 min of
reperfusion completely abolished the beneficial effect of rIPC,
resulting in an infarct size of 56.4  4.1% (P  0.05 vs. the
rIPC group). The possible participation of NO synthase in the
rIPC cardioprotection was investigated by using L-NAME (NO
synthase inhibitor) during 10 min of reperfusion, which abol-
ished the effect of rIPC on infarct size (45.8  2.6%, P  0.05
vs. the rIPC group). It is important to mention that the admin-
istration of the adenosine A1 receptor blocker and NO synthase
inhibitor in nonpreconditioned ischemic hearts did not show
any significant differences in infarct size.
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The role of the Akt/eNOS pathway in the rIPC cardiopro-
tection effect was confirmed by evaluating phosphorylated Akt
(Ser477) and eNOS (Ser1177) (Fig. 3). rIPC induced a significant
increase in the phosphorylation of both enzymes, which were
abolished by the administration DPCPX (adenosine A1 recep-
tor blocker) during the first 10 min of reperfusion.
Table 1 shows the effect of rIPC on mitochondria at 60 min
of reperfusion (late reperfusion). Whereas no changes were
observed in state 4 respiration rates, state 3 respiration was
significantly decreased in the I/R, rIPC, and rIPC  DPCPX
(R) groups compared with the normoxic (control) group (P 
0.001). As indicated by RCR values, I/R induced a significant
impairment of mitochondrial function (P  0.001) and the
rIPC protocol attenuated the mitochondrial damage, whereas
this effect was abolished by the administration of DPCPX and
L-NAME.
In the following experiments, we focused on the study of
the events that occur at early reperfusion (10 min of reper-
fusion). As shown in Table 2, compared with the normoxic
group, a slight, nonsignificant decrease in the mitochondrial
rest state respiration (state 4) rate was observed for the I/R
and rIPC groups, whereas the active state respiration (state
3) rate was significantly decreased (P  0.001). Therefore,
mitochondrial RCR was significantly decreased in the I/R
group compared with the normoxic group (P  0.05), which
was partially recovered in the rIPC group. These results
suggest that the I/R protocol impairs mitochondrial function
and that rIPC attenuates this effect. Moreover, a significant
decrease in mitochondrial RCR was observed in the rIPC 
DPCPX (R) and rIPC  L-NAME (R) groups (P  0.05),
suggesting that blockade of adenosine A1 receptor and NO
synthase inhibition at the beginning of reperfusion reversed
the protective effect of rIPC on mitochondrial function. Of
note is that DPCPX seemed to induce a transient effect over
mitochondrial O2 consumption in the I/R and rIPC groups,
particularly over rest state respiration at early (10 min)
reperfusion. However, this effect was not observed at later
time points (Table 1) or in the normoxic group (data not
shown) and did not interfere with the blocking effect over
rIPC cardioprotection (Fig. 2).
To deeply characterize the involvement of mitochondria in
the protective mechanisms triggered by rIPC, mitochondrial
inner membrane potential, H2O2, and ATP production rates
were assessed at 10 min of reperfusion. As shown in Fig. 4A,
the I/R protocol induced a significant decrease, by 47%, in the
DiOC6 signal (P  0.05) compared with the normoxic group,
which was reverted in the rIPC group. This result indicates that
Fig. 2. Infarct size expressed as a percentage of the left ventricular area.
Remote ischemic preconditioning (rIPC) significantly reduced the infarct size,
and this effect was abolished by the administration of 8-cyclopentyl-1,3-
dipropylxanthine (DPCPX) and NG-nitro-L-arginine methyl ester (L-NAME)
during 10 min of reperfusion (R). Œ, Individual infarct sizes. I/R, ischemia-
reperfusion. I/R group: n  9, rIPC group: n  9, rIPC  DPCPX group: n 
6, rIPC  DPCPX (R) group: n  7, rIPC  L-NAME group: n  10, I/R 
DPCPX (R) group: n  7, and I/R  L-NAME (R) group: n  6. *P  0.05
vs. the I/R group.
Fig. 3. Cardiac expression of phosphorylated Akt
(Ser473; A) and endothelial nitric oxide synthase
[eNOS (Ser1177); B] can be observed in the isch-
emia-reperfusion (I/R), remote ischemic precondi-
tioned (rIPC), and rIPC  8-cyclopentyl-1,3-dipro-
pylxanthine (DPCPX) groups (n  5–6/group) at 10
min of reperfusion (R). rIPC induced a significant
increase of Akt and eNOS phosphorylation, which
was abolished by the administration of DPCPX at
early reperfusion. *P  0.05 vs. the I/R and DPCPX
(R) groups.
Table 1. Mitochondrial respiration and RCR of isolated
mitochondria from the left ventricle of animals subjected to









Nx 29  3 162  21 5.6  0.5
I/R 25  1 43  6† 1.7  0.3§
I/R  DPCPX (R) 17  5 24  3† 2.0  0.3§
I/R  L-NAME (R) 24  3 40  1† 1.9  0.2§
rIPC 18  3 69  12† 3.8  0.7
rIPC  DPCPX (R) 26  3 72  7* 2.7  0.8‡
rIPC  L-NAME (R) 16  2 33  5† 1.9  0.3§
Values are means  SE; n  6/group. RCR, respiratory control ratio; Nx,
normoxic; I/R, ischemia-reperfusion; DPCPX, 8-cyclopentyl-1,3-dipropylxan-
thine; L-NAME, NG-nitro-L-arginine methyl ester; rIPC, remote ischemic
preconditioning; (R), when the drug was administered at reperfusion. RCR
values were calculated as state 3/state 4 respiration rates. *P  0.01 and †P 
0.001 vs. state 3 respiration in the Nx group; ‡P  0.05 and §P  0.001 vs.
RCR in the Nx group.
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I/R induces strong mitochondrial depolarization and that rIPC
prevents this effect. Moreover, a slight, nonsignificant decrease
in the DiOC6 signal was observed in the rIPC  DPCPX (R)
group, whereas the rIPC  L-NAME (R) group showed a
significant decrease, by 37% (P  0.05), compared with the
normoxic group. These data suggest that adenosine exerts a
minor contribution in the protective effect of rIPC over mito-
chondrial membrane potential, yet NO plays a more relevant
role in this scenario.
Regarding mitochondrial H2O2 production (Fig. 4B), the I/R
protocol induced a significant increase, by 33%, compared with
the normoxic group (P  0.001), whereas no differences were
observed in the rIPC group. Although no changes were also
observed in the rIPC  DPCPX (R) group, the rIPC 
L-NAME (R) group showed a significant increase in mitochon-
drial H2O2 production rate, by 79% (P  0.001 vs. the
normoxic group and P  0.01 vs. the rIPC group).
The mitochondrial ATP production rate (Fig. 4C) was sig-
nificantly decreased, by 67%, in the I/R group compared with
the normoxic group (P  0.01). This effect was attenuated by
rIPC, as the ATP production rate decreased by only 28% (P 
0.05) compared with the normoxic group. This effect was
abolished by blockage of adenosine A1 receptors and NO
synthase inhibition at the beginning of reperfusion, as the
mitochondrial ATP production rate in the rIPC  DPCPX (R)
and rIPC  L-NAME (R) groups were significantly decreased,
by 85% and 87%, respectively, compared with the normoxic
group. These findings indicate that rIPC prevents the induced
decrease in mitochondrial ATP production by the I/R protocol.
This effect seems to be dependent on adenosine signaling
through adenosine A1 receptor activation, in which NO plays a
central role.
It is important to mention that the administration of the
adenosine A1 receptor blocker and NO synthase inhibitor in
nonpreconditioned ischemic hearts did not show any signifi-
cant differences in the different variables of mitochondrial
function.
DISCUSSION
In the present study, we demonstrated the participation of
adenosine A1 receptors in the rIPC mechanism, considering its
activation before myocardial ischemia and at the time of
myocardial reperfusion. Moreover, the activation of adenosine
A1 receptors at early reperfusion is associated with higher
phosphorylation of Akt/eNOS and an improvement of mito-
chondrial function, supporting the notion that the mitochon-
drion is a myocardial target organelle in the mechanisms of the
rIPC-protective effect.
Adenosine was the first signaling molecule involved as a
trigger of “classic” ischemic preconditioning (33). During
normoxia, most synthesized adenosine is derived from S-
adenosylhomocysteine. During ischemia or hypoxia, however,
the major pathway of adenosine production is shifted to the
5=-AMP pathway (25). This adenosine could activate adeno-
sine receptors. In this sense, at least by classic ischemic
preconditioning, Kuno et al. (30) demonstrated that this car-
dioprotective strategy increases the heart’s sensitivity to aden-
osine so that endogenous adenosine can activate survival ki-
nases during reperfusion.
Adenosine A1 receptors are localized on cardiomyocytes
(38), and all adenosine receptors are coupled to G proteins (Gs
or Gi) (37, 38). Downstream of the different G proteins, the
eNOS/PKG and reperfusion injury salvage kinase (RISK) sig-
nal transduction pathways are activated by adenosine (24). We
and others have evaluated the effect of exogenous adenosine
administration on infarct size and ventricular function (2, 14).
Other authors studying the role of the adenosine receptor as a
mediator of rIPC have explored its contribution either in the
remote organ or tissue or in the heart but before myocardial
ischemia (25, 40). Pell et al. (40) demonstrated that a remote
renal preconditioning reduces myocardial infarction. This car-
dioprotective effect was abolished by a nonselective adenosine
receptor blocker, suggesting the involvement of adenosine
receptors in mediating acute preconditioning of the myocar-
dium. Similarly, Takaoka et al. (46) also described that remote
renal preconditioning significantly reduces infarct size and
improves myocardial energy metabolism in rabbit hearts sub-
jected to I/R through the activation of adenosine receptors.
Dong et al. (15) showed that remote limb ischemic precondi-
tioning that induces protective effects against sustained I/R
injury was abolished after femoral nerve transection and DP-
CPX administration, suggesting the involvement of local aden-
osine release and activation of the neural pathway in mediating
remote limb ischemic preconditioning. Other authors have
demonstrated the participation of adenosine A1 receptors in
rIPC cardioprotective effects, but with the use of an adenosine
A1 receptor knockout mice model (43). However, none of these
studies investigated the participation of adenosine receptors at
the beginning of reperfusion, considering the effect of its
activation on mitochondrial function. In the present study, we
showed the relevance of adenosine A1 receptor activation only
during reperfusion to achieve cardioprotection and improved of
mitochondrial function.
As mentioned above, adenosine is able to directly induce
NO production in cardiomyocytes by activation of eNOS (48).
Adenosine can activate phosphatidylinositol 3-kinase (29),
leading to increased eNOS activity. In the present study, we
showed that rIPC increases Akt phosphorylation during reper-
Table 2. Mitochondrial respiration and RCR of isolated
mitochondria from the left ventricle of animals subjected to









Nx 35  7 210  13 5.8  0.8
I/R 21  4 79  16† 3.9  0.5‡
I/R  DPCPX (R) 39  6 93  17† 3.2  0.5‡
I/R  L-NAME (R) 29  4 91  20† 3.6  0.4‡
rIPC 16  3 87  14† 5.4  1.0
rIPC  DPCPX (R) 61  9* 146  16§ 2.5  0.8‡
rIPC  L-NAME (R) 28  2 90  3†§ 2.9  0.2‡
Values are means  SE; n  6/group. RCR, respiratory control ratio; Nx,
normoxic; I/R, ischemia-reperfusion; DPCPX, 8-cyclopentyl-1,3-dipropylxan-
thine; L-NAME, NG-nitro-L-arginine methyl ester; rIPC, remote ischemic
preconditioning; (R), when the drug was administered at reperfusion. RCR
values were calculated as state 3/state 4 respiration rates. *P  0.01 vs. state
4 respiration in the Nx group; †P  0.001 vs. state 3 respiration in the Nx
group; ‡P  0.05 vs. RCR in the Nx group; §P  0.05 vs. state 3 respiration
in the I/R and rIPC groups.
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fusion and that this effect is mediated by adenosine A1 receptor
activation. We also noted that rIPC induced eNOS phosphor-
ylation, which was inhibited by L-NAME administration.
Because of this, mitochondria are viewed as end effectors of
ischemic preconditioning (49), and the preservation of mito-
chondrial function after I/R is a key event that might determine
the survival of cardiomyocytes (19, 22, 23, 28). In rats, the
myocardial infarct size reduction by rIPC was associated with
preserved mitochondrial morphology (6, 18) and retained mi-
tochondrial membrane potential and increased mitochondrial
manganese superoxide dismutase activity (5, 26). Furthermore,
reactive oxygen species (ROS) at high levels do play an
adverse role in myocardial I/R injury but contribute to endog-
enous cardioprotection at lower concentrations (7).
In this sense, Gedik et al. (19) showed that plasma obtained
from rIPC pigs improves mitochondrial function in early rep-
erfusion of isolated rat hearts. However, plasma of precondi-
tioned pigs contains different substances that are released in the
ischemic tissue (adenosine, bradykinin, etc.), which can protect
from I/R injury. Furthermore, studies performed in patients
undergoing cardiovascular surgery (28, 44) showed that rIPC
preserved mitochondrial and contractile function of the human
atrial trabeculae of patients.
On the other hand, NO can modulate the mitochondrial
permeability transition pore (mPTP) in isolated mitochondria
(1). The mPTP is a nonspecific channel that induces depolar-
ization of the mitochondrial inner membrane, leading to ATP
depletion and enhancing colloidal osmotic pressure in the
mitochondrial matrix, producing matrix swelling and rupture
of the mitochondrial outer membrane (21). The fact that NO
can alter the sensitivity of mitochondria to mPTP inducers
might be important for some physiological and pathophysio-
logical processes where the mitochondrial permeability transi-
tion has been implicated. A physiological NO concentration
may inhibit the mPTP by S-nitrosylation-related mechanisms
(39). The mPTP induces mitochondrial swelling and mem-
brane depolarization and provides a mechanism for cyto-
chrome c release, a hallmark signal protein of the mitochon-
drial apoptosis pathway (9). Thus, several studies (45, 47) have
shown that NO production can protect the heart against I/R
injury.
In the present report, we showed that rIPC increases eNOS
phosphorylation, resulting in an improvement in mitochondrial
respiration and a reduction in myocardial infarct size. This bene-
ficial effect was mediated by adenosine A1 receptor activation.
Fig. 4. Evaluation of mitochondrial function in freshly
isolated heart mitochondrial samples (n  6/group). A:
inner membrane potential was studied by flow cytom-
etry and the potentiometric cationic probe 3,3=-dihexy-
loxacarbocyanine iodide (DiOC6). B: fluorometric as-
sessment of the H2O2 production rate by the Amplex
red/horseradish peroxidase method. C: ATP production
rate evaluation by the luciferin-luciferase method. *P 
0.05 vs. the normoxic (Nx) group; **P  0.01 vs. the
Nx group; ***P  0.001 vs. the Nx group; ##P  0.01
vs. the ischemia-reperfusion (I/R) group.
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The evaluation of mitochondrial RCR by high-resolution
respirometry is the most useful general measure of mitochon-
drial function, as it encompasses every single aspect of the
oxidative phosphorylation process, including membrane poten-
tial across the inner mitochondrial membrane (4). Improved
mitochondrial respiration after rIPC was also associated with
restored mitochondrial RCR at early reperfusion, suggesting a
possible inhibition of mPTP opening, as indicated by mito-
chondrial membrane potential and H2O2 production measure-
ments. It is well known that the first minutes of reperfusion
after sustained ischemia have been emphasized as critical for
signal transduction of cardioprotection and mitochondrial func-
tion. In the present study, we measured mitochondrial function
at 10 min (early) and 60 min (late) of myocardial reperfusion.
Interestingly, the I/R group showed a progressive impairment
of mitochondrial function (indicated by RCR) along the rep-
erfusion period; however, the beneficial effect of rIPC was
maintained during this entire phase and was found to be
dependent on adenosine A1 receptor activation and NO release.
Consequently, as indicated by ATP production measurements,
this pathway triggered by rIPC preserved the mitochondrial
capacity of producing energy for the cardiomyocyte, which
might be associated with the infarct size reduction in I/R
injury. During the evaluation of the role of adenosine A1
receptor in rIPC cardioprotection, a transient effect of DPCPX
over mitochondrial respiration was observed by a yet-unknown
mechanism that did not interfere with the inhibition of rIPC
protective effect over infarct size, as we (Fig. 2) and others (17)
have reported. This observation would need to be clarified in
further studies.
In summary, in the isolated rat heart, remote ischemic limb
preconditioning limits myocardial infarction by activation of
adenosine A1 receptors and the Akt/eNOS pathway during
early reperfusion. Interestingly, remote ischemic limb precon-
ditioning appears to reduce myocardial infarct size by improv-
ing key aspects of mitochondrial function such as ATP pro-
duction during myocardial reperfusion. Further studies are
required to investigate the myocardial signal transduction path-
ways underlying rIPC to explain the association between aden-
osine A1 receptor activation and mitochondrial function.
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